Strategic partnerships ProBed Medical has recently allied with NASCIC as a sponsor and partner since late 2025, signaling increased access to clinical networks and potential referral opportunities within the spinal cord injury community.

Global expansion Past market introductions in the United Kingdom and collaboration with DRP International in Australia indicate a proactive international expansion strategy that sales teams can leverage for channel partnerships and distribution deals.

Clinical value proposition The Freedom Bed’s automated lateral rotation targets pressure relief and improved blood flow for immobilized patients, aligning with needs in hospitals, long-term care facilities, and home health where pressure injury reduction is a priority.

Mid market focus With 11-50 employees and revenue in the 1–10 million range, ProBed sits between small specialty manufacturers and larger medical device firms, opening opportunities for exclusive partnerships, pilot programs, and facility-level deployments.

Technology and data A tech-enabled therapy system and presence of analytics tags indicate opportunities to upsell monitoring, service contracts, and integration with facility IT ecosystems to optimize patient outcomes and operational efficiency.